Yüklüyor......
Lasmiditan is an effective acute treatment for migraine: A phase 3 randomized study
OBJECTIVE: To assess the efficacy and safety of lasmiditan in the acute treatment of migraine. METHODS: Adult patients with migraine were randomized (1:1:1) to a double-blind dose of oral lasmiditan 200 mg, lasmiditan 100 mg, or placebo and were asked to treat their next migraine attack within 4 hou...
Kaydedildi:
| Yayımlandı: | Neurology |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Lippincott Williams & Wilkins
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6329326/ https://ncbi.nlm.nih.gov/pubmed/30446595 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000006641 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|